Fernando Holguin, MD, describes the relationship between comorbid metabolic syndrome and pulmonary disease.
From a provider perspective, you need to encourage patients who have asthma and obesity to lose weight, said Fernando Holguin, MD, a pulmonologist and critical care doctor at the University of Colorado Anschutz Medical Campus. Holguin discussed these topics at this year's American Thoracic Society (ATS) meeting.
Transcript
How can understanding metabolic syndrome as a risk factor for pulmonary disease translate into provider/patient pulmonary disease management?
We did a study, not too long ago, using data from the Longitudinal Assessment of Bariatric Surgery study. The study had around 2500 people that underwent bariatric surgery, of which about 550 had asthma. Those patients underwent surgery and lost a significant amount of weight and were followed for up to 5 years. What's interesting is that as weight loss happens, asthma control improves. But when you look at those that, in spite of losing weight, continue to have risk factors for metabolic syndrome, regardless of which one those were, those patients remain at a higher risk of losing control. Somehow they didn't really benefit from the weight loss.
I think from a provider perspective, it is the idea that you need to encourage in patients who have asthma and obesity, weight loss, because certainly weight loss in many patients improves metabolic syndrome profiling. They have to lose at least 5% to 8% of baseline body weight. Then if somebody has metabolic syndrome and asthma, there are potentially some newer treatments that could affect both diseases. For example, let me give you an idea of one: liraglutide. Liraglutide, which is a GLP-1 [glucagon-like peptide-1] agonist to improve insulin sensitivity, it’s been used to treat patients with non–insulin dependent diabetes. That's been shown to, for one, enhance weight loss. But also, there are mechanisms that relate to inflammatory pathways and metabolic pathways, whereas GLP-1 can potentially reduce the frequency of exacerbations in patients with metabolic syndrome and obesity. That's been shown mostly epidemiologically, but there's ongoing clinical trials in that space.
The same can be said about metformin. That works more on the managing glycemic space. That drug has been associated with reduced eosinophil exacerbations in people that take it. Again, more epidemiologically, but there's some phase 2 studies that are ongoing. I think it makes sense from a clinician perspective to treat metabolic syndrome and maybe expect—I don't know for certain—maybe expect that they will have some beneficial ramifications into improving their asthma control or their lung function.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More